More Breaking News on the Flu Vaccine Frontlines
The CDC and Aventis Pasteur, the only company now providing flu vaccines, have announced a two-phase plan to distribute 22.4 million doses in a way they hopefully will be aimed at those who truly need it.
During the course of the next two months, 14.2 million doses will be distributed directly to “high-priority vaccine providers.” Part two of the plan will then dole out the emaining 8.2 million doses to areas identified as being in “high need” of influenza immunizations. How high need is defined has not been elaborated upon.
Juliie Gerberding, MD, MPH, the director of the CDC, did not have any kind words for those who are using the shortage to shore up their private bank accounts. In an article on Pharmacist.com, she is quoted as saying that price gouging is immoral, and “we are working with the state governments and hope to be able to tell you in the future that these people have been prosecuted to the full extent of the law. There’s no room for this kind of behavior in an environment where we need to pull together as a country to protect our vulnerable populations.”
Them’s fighting words, but I do think that the CDC should have been on the forefront of vaccine shortages years ago. If manufacturers were assured that they would not be taking a loss every year that they produced influenza vaccines, we would no doubt have several companies all ready and willing to make vaccines, and have a healthy supply. There is no reason that this situation should have occurred. Absolutely none.
Read more at Pharmacist.com

